Product
Shanchol™
1 clinical trial
1 indication
Indication
CholeraClinical trial
Phase III, Multicenter, Observer-Blinded, Randomized, Active Controlled Trial to Evaluate Immune Non-Inferiority, Safety and Lot-to-Lot Consistency of OCV-S Compared to Shanchol™ in 1 to 40 Years Old Healthy Nepalese ParticipantsStatus: Completed, Estimated PCD: 2022-12-22